MGAT4A

Across TCGA pan-cancer cohorts, MGAT4A mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MGAT4A data layer compared with 29 for mass-spec protein and 8 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher MGAT4A mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated MGAT4A expression acts as an unfavorable survival marker.

PDAC and LUAD are the cancer types where MGAT4A mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	All	0.296	0.676	.004	44	view →
LUAD	OS	Tertile	II,III,IV	0.440	1.000	.015	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MGAT4A–PDAC (OS)

Open the PDAC breakdown →